Matsushita, Hiroki
Kurono, Koki
Nakabayashi, Mikie
Sato, Kei
Morita, Hidetaka
Yoshida, Yuki
Fukumitsu, Masafumi
Uemura, Kazunori
Kawada, Toru
Ichinose, Masashi
Ono, Yumie
Saku, Keita https://orcid.org/0000-0002-6856-9362
Funding for this research was provided by:
Japan Society for the Promotion of Science (24K19018, 24K23449, 24K00885, 22K08222, 23K27978)
Japan Agency for Medical Research and Development (24hk0102085h0003, 24ama121050j0003)
Ministry of Internal Affairs and Communications (SCOPE: JP225006004)
National Cerebral and Cardiovascular Center (24-B-7)
Japan Science and Technology Agency (JPMJPF2018)
Article History
Received: 21 January 2025
Accepted: 19 May 2025
First Online: 1 June 2025
Declarations
:
: The protocol for this study was approved by the Institutional Animal Care and Use Committee at the National Cerebral and Cardiovascular Center, Suita, Japan (ID: 24003).
: Not applicable.
: Kawada T received consulting fee from NTT Research, Inc. Saku K received research funding from Abiomed Inc., NTT Research, Inc., Asahi Kasei ZOLL Medical Corporation, Neuroceuticals Inc., and Zeon Medical Inc., and honoraria from Abiomed Japan K.K., Mallinckrodt Pharma K.K., and Ono Pharmaceutical Co., Ltd.